Drugs Containing Excipient (Inactive Ingredient) SODIUM HYDROXIDE

Branded drugs containing SODIUM HYDROXIDE excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Eli Lilly and Company	MOUNJARO	tirzepatide	0002-1506	SODIUM HYDROXIDE	2036-01-05
Eli Lilly and Company	ZEPBOUND	tirzepatide	0002-2506	SODIUM HYDROXIDE	2036-01-05
Eli Lilly and Company	GEMZAR	gemcitabine hydrochloride	0002-7501	SODIUM HYDROXIDE
Eli Lilly and Company	ALIMTA	pemetrexed disodium	0002-7640	SODIUM HYDROXIDE
Eli Lilly and Company	FORTEO	teriparatide	0002-8400	SODIUM HYDROXIDE
ER Squibb & Sons LLC	KENALOG-40	triamcinolone acetonide	0003-0293	SODIUM HYDROXIDE

Generic drugs containing SODIUM HYDROXIDE excipient

Company	Ingredient	NDC	Excipient
Eli Lilly and Company	ixekizumab	0002-1445	SODIUM HYDROXIDE
Eli Lilly and Company	tirzepatide	0002-1506	SODIUM HYDROXIDE
Eli Lilly and Company	tirzepatide	0002-2506	SODIUM HYDROXIDE
Eli Lilly and Company	gemcitabine hydrochloride	0002-7501	SODIUM HYDROXIDE
Eli Lilly and Company	insulin lispro	0002-7510	SODIUM HYDROXIDE
Eli Lilly and Company	insulin lispro	0002-7511	SODIUM HYDROXIDE

Market Dynamics and Financial Trajectory for Sodium Hydroxide in the Pharmaceutical Excipients Sector

Last updated: February 12, 2026

Overview

Sodium hydroxide (NaOH) is a highly caustic alkali used extensively in pharmaceutical manufacturing as a pH adjuster, cleaning agent, and reagent. Its application as a pharmaceutical excipient hinges on its ability to neutralize acids, facilitate drug synthesis, and maintain product stability. The market for NaOH in pharma excipients intersects with the broader chemical industry but displays distinct dynamics driven by regulatory standards, manufacturing demand, and raw material sourcing.

Market Size and Growth Trends

The global sodium hydroxide market was valued at approximately USD 60 billion in 2022, with the pharmaceutical segment representing a growing subset expected to expand at a compound annual growth rate (CAGR) of 4-5% through 2030. While pharmaceutical-specific data is sparse, industry reports suggest the pharmaceutical excipient sector accounts for roughly 12-15% of total NaOH consumption worldwide.

Key growth drivers include:

• Increasing pharmaceutical production: The rising prevalence of chronic diseases and the growth of biopharmaceuticals necessitate chemical processes requiring NaOH.

• Regulatory compliance: The demand for high-purity NaOH (USP grade) compatible with pharmaceutical standards propels segment growth.

• Process innovation: New manufacturing techniques and drug formulations utilizing NaOH bolster market demand.

Key Market Factors

Factor	Impact	Source/Notes
Regulatory Standards	Drive demand for high-quality, pharmaceutical-grade NaOH	US and European Pharmacopeias mandate strict quality; USP <791>
Raw Material Supply	Dependence on caustic soda and electrical energy influences pricing	Chloralkali process, coal, and natural gas pricing impact margins
Environmental Policies	Push for cleaner production, influencing manufacturing costs	Regulations in key markets (e.g., EU), favoring eco-friendly methods
Global Manufacturing Shifts	Expansion in Asia-Pacific and shifts from traditional markets	China and India increasing production capacity

Price Trends and Profitability

NaOH prices have exhibited volatility, influenced by raw material costs, energy prices, and geopolitical factors. Notably:

• Pre-2020: Prices hovered around USD 400-500/tonne.
• Post-2020: Prices surged to USD 600-700/tonne due to supply chain disruptions and increased energy costs.
• 2023 Trends: Prices stabilized around USD 600/tonne but remain susceptible to market volatility.

Profit margins for manufacturers in pharma-grade NaOH vary from 10-15%, influenced by the purity requirements and regulatory compliance costs.

Major Players and Market Share

Company	Approximate Market Share	Key Attributes
OxyChem	20%	Large capacity, integrated chlor-alkali operations
Dow Chemical	15%	Focus on high-purity grades, innovation in sustainable production
Tosoh Corporation	10%	Strong Asian presence, N-alkali specialty products
AkzoNobel	8%	Specialty chemicals, focus on eco-friendly processes
Others	47%	Regional manufacturers, niche producers

This competitive landscape is consolidating, with recent M&A activity aiming to secure raw material access and expand capacity.

Regulatory and Quality Issues

Pharmaceutical applications demand NaOH meeting USP, EP, or JP standards:

• USP Grade: Contains specific limits on impurities like chloride, iron, and heavy metals.
• Traceability: Manufacturers must ensure batch-to-batch consistency.
• Environmental Compliance: Production facilities must adhere to strict environmental policies, influencing capital expenditure and operating costs.

Future Outlook

Prospects for NaOH as a pharmaceutical excipient hinge on:

• Continued expansion in biopharmaceutical manufacturing.
• Regulatory shifts favoring greener production methods.
• Innovations in drug synthesis processes reducing reliance on traditional caustic soda.

In the medium term, the market is expected to grow at a steady CAGR of approximately 4.5%, driven by the ongoing demand for pharmaceutical actives and excipients.

---

Key Takeaways

• The overall NaOH market is expanding, with pharmaceutical applications contributing an increasing share.
• Prices have been volatile but are expected to stabilize within a range influenced by energy costs.
• High regulatory standards create barriers to entry but also opportunities for specialized, high-purity products.
• Market concentration remains significant, with key players maintaining substantial market shares.
• Environmental and sustainability factors are shaping production processes and costs.

---

FAQs

1. What factors most affect NaOH prices in the pharmaceutical sector?
Raw material costs, energy prices, and regulatory compliance costs are primary drivers. Geopolitical events can also impact supply chains and pricing.

2. How does regulatory compliance impact NaOH manufacturers?
Manufacturers must produce high-purity grades meeting strict quality standards, requiring investment in quality control and certification, which increases production costs.

3. What raw materials influence the manufacture of pharmaceutical-grade NaOH?
Chlorine and caustic soda are produced via the chlor-alkali process, which depends on electrolytic methods powered by electricity, impacting raw material costs and sustainability.

4. What trends are expected in the supply chain for pharmaceutical NaOH?
Increased capacity in Asia, consolidation among top producers, and a shift toward greener manufacturing are observable trends.

5. How sustainable is the NaOH supply for pharmaceuticals?
While traditional methods depend on energy-intensive processes, advancements aim to incorporate renewable energy and environmentally friendly technologies, though adoption varies regionally.

---

Citations

1. MarketsandMarkets – Sodium Hydroxide Market by End-Use Industry (Pharmaceuticals, Paper, Textiles), Region, and Grade – Forecast to 2027.
2. US Pharmacopeia (USP) – USP <791> pH Measurement standards.
3. IHS Markit – Global Chemical Industry Reports, 2022.
4. ChlorAlkali Market Reports, 2022.
5. Industry Regulatory Filings – European Commission Regulations on Chemical Manufacturing, 2021.

[1] MarketsandMarkets.
[2] USP.
[3] IHS Markit.
[4] ChlorAlkali Market Reports.
[5] European Commission.